Stem Cells for Erectile Dysfunction Post RALP

Summary

This is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in patients undergoing radical retropubic prostatectomy (RALP) of localized prostate cancer.

Timeline

Start

2026-07-07

Primary completion

2027-06-30

Completion

2027-06-30

Drugs

Indications